Investor Relations

IR Home

IR Home

Recent News
6/22/20
iTotal® Identity PS joins iTotal® Identity CR as the latest personalized knee technology from Conformis BILLERICA, Mass. , June 22, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation
5/28/20
Conformis and Zimmer Biomet settled disputes related to Patient-Specific Instrument Patents for Use with Off-the-Shelf Knee, Hip, and Shoulder Implants BILLERICA, Mass. , May 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license
Upcoming Events
More events are coming soon.
IR Contact  
Investor Relations
Phone: (781) 374-5598
E-mail: ir@conformis.com